Astec Lifesciences has informed that it attached reply on significant increase in the volume of security across Exchanges, in the recent past, though its E-mail Notice bearing Ref. No.: L/SURV/ONL/PV/RS/ 2022-2023 /242 dated 14th October, 2022.
The above information is a part of company’s filings submitted to BSE.